On Race, Gender, and NIH Funding

The results of two studies suggest slightly different biases in the review of National Institutes of Health R01 grant applications from minority and/or women researchers.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, SEATTLE MUNICIPAL ARCHIVESLife science is dominated by white men. A 2014 report from the Association of American Medical Colleges found that men make up 62 percent of full-time medical school faculty, and the National Science Foundation found that white people (men and women) made up 71 percent of the science and engineering workforce in 2013. While the skewed numbers are obvious and persistent, the reasons for these disparities are less clear.

Two new studies aim to root out biases in funding decisions at the National Institutes of Health (NIH), but they come to somewhat different conclusions.

The first, an analysis of reviewers comments on R01 applications submitted by researchers at the University of Wisconsin-Madison between 2010 and 2014, found that while women were more likely to be praised than men in reviews of their R01 renewal applications, female applicants scored an average of four points lower than their male counterparts. “Even though we think we’re being objective, the truth is we grew up in a society where there are gender stereotypes, and they unconsciously impact our assessments of people,” Anne Wright, a medical anthropologist at the University of Arizona who wasn’t involved in the study, told ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies